NYSE: PEN

Penumbra (PEN) Stock Analysis & Forecast

Nov 13 close

$320.91+0.14 (0.0%)

Gekko Brief

AI summaryNov 9 close

Penumbra's most recent quarter, reported 29 October, showed earnings of $1.07 per share against an estimate of $1.20, and the stock's reaction to that report was muted at 0.2%. With no fresh headlines this week, the stock's standing reflects that recent print and its position relative to its own trend lines rather than any new catalyst.

Penumbra closed at $321.85, up 0.8%, sitting between its 50-day average of $320.24 and 200-day average of $326.46, a mixed trend picture. The GekkoIndex reads 58.8, placing the stock in the Neutral zone. Shares trade 4.5% below Gekko Fair Value of $337.16, within the 52-week range of $259.14 to $362.41. Over the past year the stock has returned 21.6%, though its three-month return is -1.4% and six-month flat at 0%.

The next earnings date falls on 24 February 2027, 106 days out and beyond a typical 20-trading-day holding window, with prior reports showing an average absolute reaction of 5.6% and 5 beats across the last 8 quarters. No insider, Congress or unusual options activity appears in their respective 90-day and 30-day windows, and one trailblazer holder is recorded. Seasonally, the next 20 trading days have averaged an 8.4% gain over 5 years, rising in 4 of those years. Coverage remains limited to 2 firms, both at hold, with a consensus target of $362.54 implying 12.6% upside from current levels.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Penumbra price vs fair value

$337.11$320.91Nov ’25May ’26Nov ’26
Close $320.91200-day averageGekko Fair Value $337.11

Penumbra quick facts

Market cap
$12.65B
P/E ratio
80.8
Forward P/E
55.9
EPS, TTM
$3.97
Revenue, TTM
$1.56B
Profit margin
10.1%
Dividend yield
—
Beta
0.69
Volume
237,594 avg 394,050
1-year return
+14.5%
Typical daily move
±1%
Typical 20-day move
±6.9%
50-day average
$320.15
200-day average
$325.71
Next earnings
Feb 24 after close
Shares outstanding
39.41M
52-week range
$274.20$362.41

Penumbra swing-trade checklist

Penumbra scores 2 supportive, 3 mixed and 0 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

2 supportive3 mixed0 headwinds

  • Trendmixed

    Averages disagree

    Close $320.91 sits between the 50-day ($320.15) and 200-day ($325.71) averages, or the averages disagree.

    See the chart
  • GekkoIndexmixed

    59.1, Neutral

    Reading 59.1 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuemixed

    4.8% below

    Price is within 5% of Gekko Fair Value (4.8% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 101 days

    Next report Feb 24, 2027, 101 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +8.4% on average

    From this point in the calendar, the next 20 trading days averaged +8.4% over 5 years, rising in 4 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Penumbra stock chart and price history

Penumbra closed at $320.91 on Nov 13, 2026, +14.5% over the past year, inside a 52-week range of $274.20 to $362.41.

Close50-day average200-day averageVolume
Penumbra share price, past year, with 50-day and 200-day moving averages and volume$260$280$300$340$360DecJan 2026FebMarAprMayJunJulAugSepOctNov320.91

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−0.1%
3 months
−1.9%
6 months
−0.4%
1 year
+14.5%
The full PEN chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open PEN in Gekko

Follow Penumbra through every session

Put PEN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track PEN in GekkoFree for 7 days. No credit card required.

About Penumbra

Penumbra designs, manufactures and sells medical devices used to treat vascular and neurological conditions, with products sold across the United States and in other countries. It is best known for its thrombectomy systems, tools that use vacuum or mechanical aspiration to clear blood clots from vessels in the body and brain, including devices such as the Indigo System, Lightning Flash and Lightning Bolt 7.

Beyond thrombectomy, Penumbra makes a wide set of related tools, among them guide catheters and delivery catheters for accessing blood vessels, an integrated reperfusion system for mechanical thrombectomy, coiling systems used to treat aneurysms and other vascular lesions, embolization devices for peripheral use, and a neurosurgical device for removing fluid and tissue from the brain. These products reach hospitals and medical practitioners through the company's own direct sales teams as well as through outside distributors.

Penumbra was incorporated in 2004 and operates out of Alameda, California. Its shares are listed on the NYSE under the ticker PEN.

Listed
NYSE
Sector
Health technology
Industry
Medical specialties
Website
penumbrainc.com

Penumbra GekkoIndex: the smart money zone

Penumbra’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 59.1, in the Neutral zone, down 1.7 points over five sessions.

010059.1Neutral

Down 1.7 points over five sessions, from the Accumulation zone.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying32+2.2%+5.7%+7.4%+6.2%
Accumulation2960.0%−0.3%−0.7%+0.1%
Neutral (current zone)337+0.5%+1.1%+2.2%+5.2%
Distribution36−1.3%−3.0%−1.8%−0.8%
Selling1Too few readings yet

Average PEN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the PEN price, zone by zone.Track PEN in Gekko

Is Penumbra stock overvalued? Gekko Fair Value

Penumbra trades 4.8% below Gekko Fair Value of $337.11, so the shares are about fair value on Gekko’s estimate.

Gekko’s own estimate of what Penumbra shares are worth, recalculated every trading day.

$337.11

Gekko Fair Value, Nov 14, 2026

4.8% below fair value · About fair value

At the end of Aug 2026 the price was 7.0% below the estimate.

Gekko Fair ValueShare price, month end
$337$321Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open PEN in Gekko

Penumbra insider and Congress trading

No open-market insider purchases were filed for Penumbra, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for PEN in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every PEN insider filing, plotted on the chart in Gekko.Open PEN in Gekko

Congress trades last 90 days

No trades in PEN were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for PEN, plotted on the chart in Gekko.Open PEN in Gekko

Buybacks

Penumbra has been buying back its own shares.

Bought back, quarter ended Sep 30, 2026
$1.29M
As a share of market cap
0.01%

From company filings.

Hedge funds and billionaires quarter ended Jun 30

1of the funds Gekko tracks holds PEN.

1added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko

Penumbra earnings: next date and track record

Penumbra reports on Feb 24, 2027, after the close (101 days away), and beat the EPS estimate in 5 of its last 8 reports.

5 of 8reports beat the EPS estimate
±5.6%average move across the report
8 of 8reports followed by a gain

Share-price move across each report

+13.1%Feb ’25+7.6%Apr ’25+10.4%Jul ’25+12.6%Nov ’25+0.7%Feb ’26+0.2%May ’26+0.3%Jul ’26+0.2%Oct ’26
ReportedEPSSurpriseRevenueSurpriseMove
Oct 29, 2026$1.07
est $1.20
−10.8%$410.1M
est $401.4M
+2.2%+0.2%
Jul 30, 2026$0.88
est $1.15
−23.5%$390.0M
est $389.6M
+0.1%+0.3%
May 6, 2026$1.01
est $1.06
−4.7%$374.8M
est $370.5M
+1.2%+0.2%
Feb 25, 2026$1.18
est $1.10
+7.3%$385.4M
est $361.9M
+6.5%+0.7%
Nov 5, 2025$0.97
est $0.93
+4.4%$354.7M
est $341.0M
+4.0%+12.6%
Jul 29, 2025$0.86
est $0.81
+6.2%$339.5M
est $341.3M
−0.6%+10.4%
Apr 23, 2025$0.83
est $0.67
+23.9%$324.1M
est $327.3M
−1.0%+7.6%
Feb 18, 2025$0.97
est $0.89
+8.5%$315.5M
est $311.6M
+1.2%+13.1%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Penumbra stock forecast and analyst price targets

Analysts’ average 12-month price target for Penumbra is $362.54, +13.0% from the last close, from 3 firms rating the stock in the last 90 days.

$362.54consensus 12-month target, +13.0% from the last close
Low $350High $374
Buy0
Hold3
Sell0

Each firm’s latest rating in the last 90 days: 3 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 12UBSHold, maintained$374+16.5%
Oct 30RBC CapitalHold, maintained$374+16.5%
Oct 5CitiHold, maintained$350+9.1%
Oct 1RBC CapitalHold, maintained$374+16.5%
+2.2%average 20-day move after past Neutral readings
+8.4%average move over the next 20 trading days in the last 5 years
±1%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Penumbra seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Penumbra averaged +8.4% across the last 5 years, rising in 4 of them.

Next 20 trading days, by year

−3.7%2021+16.5%2022+11.8%2023+5.2%2024+10.4%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+2.4%4 of 5
Next 10 trading days+2.3%4 of 5
Next 15 trading days+4.5%4 of 5
Next 20 trading days+8.4%4 of 5
Next 30 trading days+11.1%5 of 5

For scale, PEN’s typical 20-trading-day move in either direction is about 6.9%.

Penumbra market cap and key statistics

Penumbra’s market cap is $12.65B, with a P/E ratio of 80.8 and revenue of $1.56B over the last twelve months.

Valuation

Market cap
$12.65B
P/E ratio
80.8
Forward P/E
55.9
EPS, TTM
$3.97
Gekko Fair Value
$337.11

Trading

Volume
237,594
Avg volume, 20 days
394,050
52-week high
$362.41
52-week low
$274.20
Shares outstanding
39.41M

Financials

Revenue, TTM
$1.56B
Profit margin
10.1%
Return on equity
10.7%
Quarterly earnings growth, YoY
−8.5%

Risk and income

Beta
0.69
Typical daily move
±1%
Typical 20-day move
±6.9%

Penumbra peers

Penumbra’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
TMOThermo Fisher Scientific−0.2%Neutral15.0% above
ABTAbbott Laboratories+0.3%Neutral10.5% below
DHRDanaher0.0%Neutral4.7% above
ISRGIntuitive Surgical0.0%Neutral17.5% above
MDTMedtronic+0.7%Neutral14.2% below
SYKStryker−2.0%Neutral0.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Medical specialties

Penumbra stock FAQ

What is Penumbra’s market cap?

Penumbra’s market cap is $12.65B at the Nov 13, 2026 close of $320.91, with 39.41M shares outstanding. The shares trade on a P/E ratio of 80.8.

What is the Penumbra stock forecast?

The consensus analyst 12-month price target for Penumbra is $362.54, +13.0% from the last close. Of the 3 firms that rated the stock in the last 90 days, 0 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Penumbra stock overvalued or undervalued?

On Gekko’s estimate Penumbra is about fair value: the Nov 13, 2026 close of $320.91 is 4.8% below Gekko Fair Value of $337.11. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Penumbra report earnings next?

Penumbra is expected to report on Feb 24, 2027, after the market closes (101 days away). Analysts expect earnings of $1.44 per share on revenue of $430.4M. Penumbra beat the earnings estimate in 5 of its last 8 reports, moving 5.6% on average across the report.

What is Penumbra’s 52-week high and low?

Penumbra’s 52-week high is $362.41 and its 52-week low is $274.20; it closed at $320.91 on Nov 13, 2026, +14.5% over the past year.

Is Penumbra stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (earnings risk and seasonality), 3 as mixed (trend, gekkoindex and fair value). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Penumbra the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.